verified
SJR 12,135 · Q1
•
database
Scopus / SJR & Web of Science indexed
United Kingdom · Springer Nature
workspace_premium
Q1 — Genetics
lock_open
Open Access
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy is a journal indexed in SJR in Genetics and Cancer Research with an H index of 161. It is an CC BY Journal It has a price of 2490 €. It has an SJR impact factor of 12,135 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 12,135.
ISSN: 2059-3635
Publisher: Springer Nature
Category: Genetics
Indexation:
verifiedScopus / SJR
verifiedWeb of Science
open_in_new Portal NPD
menu_book Guidelines NPD
schedule
CountryOfPapers database fields
SJR Impact Factor
trending_up
12,135
Q1
H-index
161
Acceptance rate
pie_chart
30%
Selective
Source
Acceptance_Rate
Time to publication
hourglass_top
NPD
Field
NPD
Publication cost (APC)
payments
2.490 €
Open Access
Non-OA path
NPD
Metrics
Scimago and CountryOfPapers database fields
Scopus / SJR
Web of Science
SJR Impact
12,135
H-index
161
Docs (year)
365
Docs 3y
1269
Total refs
61560
Cites 3y
36770
Citable 3y
806
Cites/Doc 2y
29.1
Ref/Doc
168.66
Immediate OA
2490 €
Embargoed OA
NPD
Non OA / Submission
—
shield
Researcher voice
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Fair & fast peer review
Clear APC / no surprise fees
Suspected predatory
Fake impact claims
Researcher reviews
sentiment_dissatisfied
No reviews yet — be the first to share an honest experience.